myirislogo
26 November, 2014 15:23 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 306.25 0.43
Bhel 271.15 2.24
Hindalco In 169.25 2.27
Ntpc 141.45 1.04
Sun Pharma 838.90 0.16
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Abbott India Limited
Abbott India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500488NSE:ABBOTINDIABloomberg:BOOT@INReuters:ABOT.BO
Market Lot: 1Face Value: 10ISIN Demat: INE358A01014
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
05-MAY-14 ABB, a leading player in power and automation technologies, today reported a rise of 20.02% in consolidated net profit to Rs 516.8 million for the quarter ended Mar. 31, 2014 as compared to Rs 430.6 million in the same period last year. 04-JUN-13 Abbott India announced that the board of directors has decided to defer the proposal received by the company for the sale and transfer of other appropriate restructuring of, the proprietary ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Abbott India standalone quarterly earnings rise 20.34%   -IRIS 23-Jul-14
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Sep-2014(9)31-Dec-2013(12)31-Dec-2012(12)
Net sales 15728.8017527.4016130.90
Other Income312.00388.30223.10
Total Income16040.8017915.7016354.00
Cost of goods sold14013.0015851.1014508.90
OPBDIT2027.802064.601845.10
PAT1530.701600.601447.00
Gross Block---
Equity capital212.50212.50212.50
EPS (Rs.)---
DPS (Rs.)---
BV (Rs.)---
P/E range (x)---
Debt / Equity (x)---
Operating margin (% of OI)12.611.511.3
Net margin (% of OI) 9.5 8.9 8.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
3 - 4, Corporate Park
Sion Trombay Road
Mumbai
Maharashtra-400 071
PHONE
(022) 6797 8888
FAX
(022) 6797 8727
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer